{
    "clinical_study": {
        "@rank": "119373", 
        "brief_summary": {
            "textblock": "To confirm the safety and efficacy of Bydureon subcutaneous injection 2 mg (hereinafter\n      referred to as Bydureon) in long-term use in Japanese patients with type 2 diabetes mellitus\n      under actual drug use."
        }, 
        "brief_title": "Specific Clinical Experience Investigation for Long-term Use of Bydureon Subcutaneous Injection 2 mg", 
        "completion_date": {
            "#text": "August 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "To confirm the safety and efficacy of Bydureon subcutaneous injection 2 mg (hereinafter\n      referred to as Bydureon) in long-term use in Japanese patients with type 2 diabetes mellitus\n      under actual drug use.\n\n        1. Primary Objective To confirm the safety profile in Japanese patients with type 2\n           diabetes mellitus receiving Bydureon under daily practices.\n\n        2. Secondary objective As the secondary objective of this S-CEI, the following items are\n           to be investigated.\n\n             -  Frequencies of AEs related to cardiovascular events, hypoglycaemia, digestive\n                symptoms, and injection site reaction.\n\n             -  Development of pancreatitis, renal impairment (especially acute renal failure),\n                hypersensitivity reaction, and malignant tumour (especially thyroid tumour and\n                pancreatic malignancy)\n\n             -  Safety in patients with mild or moderate renal impairment\n\n             -  Changes of weight, blood pressure, pulse rate, fasting blood sugar, fasting\n                insulin, HbA1c,  and blood lipids\n\n             -  Bydureon administration under daily practices focusing on the patient's\n                demographics and clinical characteristics of diabetes mellitus (duration of\n                diabetes mellitus, treatment duration, complications, Bydureon administration,\n                etc)\n\n             -  Anti-exenatide antibody titer in AE cases (hypersensitivity, loss of control of\n                blood sugar)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - The patients with type 2 diabetes mellitus who inadequately respond to sulfonylurea,\n        biuguanides, and/or thiazolidines (monotherapy or combination use) in addition to diet and\n        exercise.\n\n        Exclusion Criteria:\n\n          -  No past history of hypersensitivity to the components of Bydureon.\n\n          -  Not the patient with diabetic ketoacidosis, diabetic coma/ precoma, and/ or type 1\n             diabetes mellitus.\n\n          -  Bydureon will not be administered to the patient in an emergency situation such as\n             severe infection and operation.\n\n          -  Not the patient with severe renal impairment, including those receiving dialysis."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The patients with type 2 diabetes mellitus who will be given Bydureon for the first time\n        and who inadequately respond to sulfonylurea, biuguanides, and/or thiazolidines\n        (monotherapy or combination use) in addition to diet and exercise."
            }
        }, 
        "enrollment": {
            "#text": "1100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01940770", 
            "org_study_id": "D5551C00001"
        }, 
        "intervention_browse": {
            "mesh_term": "Exenatide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Diabetes Mellitus(DM)", 
            "Bydureon", 
            "Exenatide"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Aichi", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akita", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aomori", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chiba", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ehime", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fukui", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fukuoka", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gunma", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hiroshima", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hokkaido", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hyogo", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ibaraki", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ishikawa", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iwate", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kagoshima", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kanagawa", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kumamoto", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyoto", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mie", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miyazaki", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagano", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagasaki", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nara", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Niigata", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Okinawa", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saga", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saitama", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shizuoka", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tokushima", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tokyo", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toyama", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yamaguchi", 
                        "country": "Japan"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Specific Clinical Experience Investigation for Long-term Use of Bydureon Subcutaneous Injection 2 mg", 
        "overall_contact": {
            "email": "M.Inoue@astrazeneca.com", 
            "last_name": "Maki Inoue"
        }, 
        "overall_official": {
            "affiliation": "Quality & Safety Compliance Office", 
            "last_name": "Shigeru Yoshida, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Japan: Ministry of Health, Labor and Welfare", 
                "Japan: Pharmaceuticals and Medical Devices Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of Adverse Drug Reactions", 
            "measure": "Adverse event incidence", 
            "safety_issue": "Yes", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01940770"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change value of HbA1c from baseline as mean.", 
                "measure": "Mean change of HbA1c", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of weight from baseline as mean.", 
                "measure": "Mean change of weight", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of blood pressure from baseline as mean.", 
                "measure": "Mean change of blood pressure", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of lipid metabolism from baseline as mean.", 
                "measure": "Mean change of lipid metabolism", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of HbA1c from baseline as median.", 
                "measure": "Mean change of HbA1c", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of HbA1c from baseline as minimum.", 
                "measure": "Mean change of HbA1c", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of HbA1c from baseline as max.", 
                "measure": "Mean change of HbA1c", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of weight from baseline as median.", 
                "measure": "Mean change of weight", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of weight from baseline as minimum.", 
                "measure": "Mean change of weight", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of weight from baseline as max.", 
                "measure": "Mean change of weight", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of blood pressure from baseline as median.", 
                "measure": "Mean change of blood pressure", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of blood pressure from baseline as minimum.", 
                "measure": "Mean change of blood pressure", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of blood pressure from baseline as max.", 
                "measure": "Mean change of blood pressure", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of lipid metabolism from baseline as median.", 
                "measure": "Mean change of lipid metabolism", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of lipid metabolism from baseline as minimum.", 
                "measure": "Mean change of lipid metabolism", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }, 
            {
                "description": "Change value of lipid metabolism from baseline as max.", 
                "measure": "Mean change of lipid metabolism", 
                "safety_issue": "No", 
                "time_frame": "from baseline up to 3 years"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}